Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

Study data from 42,135 breast cancer survivors were pooled using statistical modelling to assess the relationship between an unhealthy metabolic profile and survival of breast cancer. The pooled ...

Experts are warning against overusing these common cooking oils because they contain a fat that is reportedly linked to breast cancer. Seed and vegetable oils don’t have the best reputation ...

Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly ...

Olivia Williams opened up about her harrowing journey with pancreatic cancer, revealing she experienced years of misdiagnoses and dismissals by doctors. The professionally trained British actress ...

Being obese makes breast cancer survivors up to 80 per cent more likely to die from the disease, alarming research has suggested. Danish researchers found women with collection of weight-related ...

Breast cancer survivor and co-founder of The Home Edit Clea Shearer says she recently underwent a “traumatizing” surgery on her right breast. “This is a difficult post to write because this ...

When Do Brain Metastases Strike in Breast Cancer Care? Brain metastases become more prevalent with each line of therapy in metastatic breast cancer and are more common in patients with certain ...

Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium). Breast ...

Gemcitabine Plus Paclitaxel Increases Survival in Metastatic Breast Cancer Time to progression is also significantly better than with paclitaxel alone, and the combination does not increase toxicity.